Clinical trial
Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients…
NCT00471848 · European Society for Blood and Marrow Transplantation, Other · Completed
Key facts
| NCT number | NCT00471848 |
|---|---|
| Title | Rabbit Antithymocyte Globulin (Thymoglobuline) With Ciclosporin for Patients With Acquired Aplastic Anaemia |
| Official title | Prospective Phase II Study of Rabbit Antithymocyte Globulin (ATG, Thymoglobuline®, Genzyme) With Ciclosporin for Patients With Acquired Aplastic Anaemia and Comparison With Matched Historical Patients Treated With Horse ATG and Ciclosporin |
| Acronym | RATGAA07 |
| Lead sponsor | European Society for Blood and Marrow Transplantation, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Aplastic Anemia |
| Intervention type | Drug |
| Interventions | rabbit antithymocyte globulin |
| Enrollment | 35 |
| Start date | Aug 1, 2008 |
| Primary completion | Oct 1, 2011 |
| Completion | Feb 1, 2013 |
| First posted | May 10, 2007 |
| Last update posted | Sep 26, 2023 |
| Countries | France, Germany, Italy, Saudi Arabia, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: